Results 41 to 50 of about 4,785,875 (311)

Davis County Utah Pride 2023 Connell O\u27Donovan Speaking [2]

open access: yes, 2023
Color photograph wide shot of Connell O\u27Donovan Speaking at the 2023 Davis County Pride ...
Jolene Mewing
core  

Evolución de la demanda de gas natural en 2022-2023 [PDF]

open access: yes, 2023
Motivación Ante la emergencia energética por la guerra de Ucrania resulta pertinente analizar el comportamiento del consumo de este producto energético por parte de hogares, empresas y sector eléctrico durante ese año y principios del 2023 para ...
Matea, María de los Llanos
core  

Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) involvement in childhood acute lymphoblastic leukemia (ALL) is assessed by cell counting and cytomorphology from cerebrospinal fluid (CSF) and is used for treatment stratification worldwide. The ratio of “CNS2” patients in clinical trials ranges from 3% to 40%, with unclear prognostic significance ...
Laura Almási   +14 more
wiley   +1 more source

Davis County Utah Pride 2023 Connell O\u27Donovan, Madazon CanCan

open access: yes, 2023
Color photograph of Connell O\u27Donovan and Madazon Can Can on stage at the 2023 Davis County Pride ...
Unknown
core  

Following the Fellows - Impact Report from funded applicants to the StandICT.eu 2023 Fellowship Programme - 8th Open Call

open access: yes, 2023
This report provides an immersion into the outcomes of the StandICT.eu 2023 Open Call #8 from the perspective of fellows that were selected and funded under this call. The primary purpose of this document is to share the results attained through the work
StandICT.eu 2023
core   +1 more source

Emapalumab for Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CD19‐Directed CAR‐T in Two Patients With B‐ALL: Clinical and Biomarker Correlates

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Immune effector cell‐associated hemophagocytic lymphohistiocytosis‐like syndrome (IEC‐HS) is a life‐threatening hyperinflammatory toxicity distinct from cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T‐cell (CAR‐T) therapy. In a single‐institution retrospective cohort of pediatric and young adult patients
Thomas J. Galletta   +6 more
wiley   +1 more source

HOTAIR requires epitranscriptomic modification to exert its pivotal epigenetic role in Epithelial to Mesenchymal Transition

open access: yesCell Death and Disease
While m6A epitranscriptomic modification has been shown to impact several mRNAs maturation, stability/degradation, nuclear/cytoplasm export and translation regulation, its impact on lncRNAs activity is yet largely uncharacterized.
Sabrina Garbo   +8 more
doaj   +1 more source

Assessment of the Geographical Factors Contributing to the Occurrence of the Flood and Flash Flood in Şanlıurfa on March 15, 2023

open access: yesDoğal Afetler ve Çevre Dergisi
Floods and flash floods are among the natural disasters that frequently occur in the world and have high destructive power. This study was prepared to evaluate the geographical factors that are effective in the formation of the flood and flash floods ...
Mustafa Recep İrcan, Neşe Duman
doaj   +1 more source

Davis County Utah Pride 2023 Connell O\u27Donovan Speaking [3]

open access: yes, 2023
Color photograph of Connell O\u27Donovan Speaking at the 2023 Davis County Pride ...
Tracy Johnson Faulkner
core  

Efficacy and Safety Analysis of Roxarestat in Regulating Renal Anemia in Patients on Maintenance Hemodialysis

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley   +1 more source

Home - About - Disclaimer - Privacy